---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-229293"
form_type: "8-K"
ticker: "LONA"
cik: "0001620463"
company_name: "LeonaBio, Inc."
filed_at: "2025-10-03T23:59:59+00:00"
generated_at: "2026-05-17T04:45:11.952898+00:00"
event_type: "regulatory"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Athira Pharma regains Nasdaq minimum bid price compliance; delisting risk removed

## Summary
- Received Nasdaq notice on Oct 2, 2025 that closing bid price was $1.00+ for ten consecutive days.
- Compliance with Nasdaq minimum bid requirement is regained and the matter is closed.
- Previously notified of deficiency on Oct 16, 2024 when stock fell below $1.00 for 30 days.

## SEC filing metadata
- accession: 0001193125-25-229293
- form_type: 8-K
- ticker: LONA
- cik: 0001620463
- company_name: LeonaBio, Inc.
- filed_at: 2025-10-03T23:59:59+00:00
- event_type: regulatory
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1620463/000119312525229293/0001193125-25-229293-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1620463/000119312525229293/atha-20251002.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-229293
- JSON: https://secwatch.observer/filing/0001193125-25-229293.json
- Plain text: https://secwatch.observer/filing/0001193125-25-229293.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.